doi: 10.1001/jama.2024.2252 21 ZakariaHAlshehhiSCaccelliMOzkanCKattanJJafaarZet al
Graphical abstract Keywords: GLP-1 receptor, GLP-1 receptor agonists, Nanoplatforms, Ligand engineering, Multimodal therapeutics, Human disease Introduction Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by intestinal L cells [1]
BDNFTrkB-CREP, brain-derived neurotrophic factor-tropomyosin receptor kinase BcAMP response element-binding protein
Crizanlizumab is a P-selectin monoclonal antibody
Seven measures of antioxidant status were determined using Trolox equivalent antioxidant capacity, uric oxidase, alpha-tocopherol, total glutathione, cytosolic glutathione peroxidase, and superoxide dismutase
When agricultural dust and oak pollen leave you feeling drained and congested, our immunity IVs with high-dose Vitamin C and anti-inflammatories help your body cope with the inflammatory response and restore your energy levels